Universidad Complutense de Madrid
E-Prints Complutense

VIP and CRF reduce ADAMTS expression and function in osteoarthritis synovial fibroblasts



Último año

Pérez García, Selene y Carrión Caballo, Mar y Gutiérrez Cañas, Irene y González Álvaro, Isidoro y Pérez Gomáriz, Rosa María y Juarranz Moratilla, Yasmina (2016) VIP and CRF reduce ADAMTS expression and function in osteoarthritis synovial fibroblasts. Journal of cellular and molecular medicine, 20 (4). pp. 678-687. ISSN 1582-4934

Vista previa
Creative Commons License
Esta obra está bajo una licencia de Creative Commons: Reconocimiento.


URL Oficial: http://onlinelibrary.wiley.com/doi/10.1111/jcmm.12777/full


ADAMTS (a disintegrin and metalloproteinase with thrombospondin motifs) family is known to play an important role in the pathogenesis of osteoarthritis (OA), working on aggrecan degradation or altering the integrity of extracellular matrix (ECM). Thus, the main purpose of our study was to define the role of vasoactive intestinal peptide (VIP) and corticotrophin-releasing factor (CRF), as immunoregulatory neuropeptides, on ADAMTS production in synovial fibroblasts (SF) from OA patients and healthy donors (HD). OA- and HD-SF were stimulated with pro-inflammatory mediators and treated with VIP or CRF. Both neuropeptides decreased ADAMTS-4, -5, -7 and -12 expressions, aggrecanase activity,glycosaminoglycans (GAG), and cartilage oligomeric matrix protein (COMP) degradation after stimulation with fibronectin fragments (Fn-fs) in
OA-SF. After stimulation with interleukin-1b, VIP reduced ADAMTS-4 and -5, and both neuropeptides decreased ADAMTS-7 production and COMP degradation. Moreover, VIP and CRF reduced Runx2 and b-catenin activation in OA-SF. Our data suggest that the role of VIP and CRF on ADAMTS expression and cartilage degradation could be related to the OA pathology since scarce effects were produced in HD-SF. In addition,their effects might be greater when a degradation loop has been established, given that they were higher after stimulation with Fn-fs. Our results point to novel OA therapies based on the use of neuropeptides, since VIP and CRF are able to stop the first critical step, the loss of cartilageaggrecan and the ECM destabilization during joint degradation

Tipo de documento:Artículo
Palabras clave:VIP, CRF, ADAMTS, Osteoarthritis, Synovial fibroblast, COMP, Glycosaminoglycans
Materias:Ciencias Biomédicas > Medicina > Reumatología
Ciencias Biomédicas > Biología > Bioquímica
Código ID:41177
Depositado:08 Feb 2017 08:25
Última Modificación:08 Mar 2017 09:50

Descargas en el último año

Sólo personal del repositorio: página de control del artículo